Dianwen Ju
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 3
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
-
- Liver Disease Diagnosis and Treatment 2
- Autophagy in Disease and Therapy 2
-
- Inflammasome and immune disorders 2
-
- Endoplasmic Reticulum Stress and Disease 2
-
- Muscle and Compartmental Disorders 1
- Co-authors
- Jiajun FanXuyao ZhangHongrui LiuWei ChenWenjing ZaiJingyun LuanZimei WuXin Jin
- Cited by
- PharmacologyImmunologyHepatology
- Journals
- Applied Microbiology and Biotechnology (4 papers)Gene Therapy (2 papers)European Journal of Organic Chemistry (1 paper)
- Partner nations
- ChinaJapanUnited Kingdom
In The Last Decade
Dianwen Ju
17 papers receiving 416 citations
Peers
Comparison fields: 5 of 73
- Pharmacology 62
- Immunology 91
- Hepatology 34
- Epidemiology 97
- Molecular Biology 178
Countries citing papers authored by Dianwen Ju
This map shows the geographic impact of Dianwen Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianwen Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianwen Ju more than expected).
Fields of papers citing papers by Dianwen Ju
This network shows the impact of papers produced by Dianwen Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianwen Ju. The network helps show where Dianwen Ju may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dianwen Ju, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 54 | |
| 5 | 2021 | 28 | |
| 6 | 2021 | 13 | |
| 7 | 2020 | 27 | |
| 8 | 2019 | 48 | |
| 9 | 2019 | 34 | |
| 10 | 2018 | 32 | |
| 11 | 2018 | 18 | |
| 12 | 2017 | 30 | |
| 13 | 2017 | 39 | |
| 14 | 2015 | 18 | |
| 15 | 2001 | 25 | |
| 16 | 2000 | 26 | |
| 17 | Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene. | 1999 | 15 |
| 18 | [Effects of Phytolacca acinosa polysaccharide on splenic lymphocyte proliferation and cytokine secretion from splenic lymphocyte and macrophage]. | 1993 | 3 |
About Dianwen Ju
Dianwen Ju is a scholar working on Pharmacology, Pharmaceutical Science, Hepatology, Oncology and Immunology, having authored 18 papers that have together received 419 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (3 papers), Immunotherapy and Immune Responses (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Immune Cell Function and Interaction (2 papers), Inflammasome and immune disorders (2 papers), Autophagy in Disease and Therapy (2 papers) and Muscle and Compartmental Disorders (1 paper). The work is most often cited by research in Pharmacology (62 citations), Immunology (91 citations), Hepatology (34 citations), Epidemiology (97 citations) and Molecular Biology (178 citations). Dianwen Ju has collaborated with scholars based in China, Japan and United Kingdom. Frequent co-authors include Jiajun Fan, Xuyao Zhang, Hongrui Liu, Wei Chen, Wenjing Zai, Jingyun Luan, Zimei Wu, Xin Jin, Xuetao Cao and Wei Chen. Their work appears in journals such as Applied Microbiology and Biotechnology, Gene Therapy, European Journal of Organic Chemistry, ACS Biomaterials Science & Engineering and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.